Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 181–195 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-394 Cow/Buffalo Meat Differentiation Test This diagnostic test identifies the species of origin in a meat sample, distinguishing between cow and buffalo.	Fresh or frozen meat tissue	1 week	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Species-specific peptide markers", "Unique DNA sequences (cow and buffalo)"] Parameters [] Preparation [] Indications ["Food authenticity verification", "Regulatory compliance", "Religious dietary adherence"] Measurement technique Confirm with laboratory Codes LOINC: 69048-7 ICD-10: Z13.9 Clinical summary This diagnostic test identifies the species of origin in a meat sample, distinguishing between cow and buffalo.
TEST-3962 CP Gene Cerebellar Ataxia Genetic Test This test evaluates for genetic variants in the CP gene and other ataxia-associated genes using Next Generation Sequencing (NGS). It identifies mutations potentially causing heredi...	Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CP gene variants", "Other ataxia-associated gene variants", "Copy Number Variants (CNVs)", "Deep Intronic Variants"] Parameters [] Preparation ["No fasting required", "Stay well-hydrated", "Continue prescribed medications unless instructed otherwise by physician"] Indications ["Clinical suspicion of hereditary cerebellar ataxia", "Family history of cerebellar ataxia"] Measurement technique Confirm with laboratory Codes LOINC: 90206-2 ICD-10: G11.9, G11.8, G11.0 Clinical summary This test evaluates for genetic variants in the CP gene and other ataxia-associated genes using Next Generation Sequencing (NGS). It identifies mutations potentially causing hereditary cerebellar ataxia.
TEST-3562 CPA1 Gene Mutation Analysis (Hereditary Pancreatitis, Early-Onset) Test This test evaluates the CPA1 gene for mutations associated with hereditary pancreatitis.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CPA1 gene sequence", "Pathogenic mutations", "Copy number variants"] Parameters [] Preparation ["No fasting required", "No medication changes needed"] Indications ["Diagnosis of hereditary pancreatitis", "Familial cascade screening", "Personalized management of pancreatic disease"] Measurement technique Confirm with laboratory Codes LOINC: 94543-9 ICD-10: K86.1 Clinical summary This test evaluates the CPA1 gene for mutations associated with hereditary pancreatitis.
TEST-6060 CPT1B (Carnitine Palmitoyltransferase 1B) Deficiency Genetic Test via Next‑Generation Sequencing (NGS) This genetic test evaluates the CPT1B gene for pathogenic variants associated with Carnitine Palmitoyltransferase 1B deficiency.	Whole Blood (EDTA) or FTA Card Blood Spot	3–4 weeks including genetic counselling	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CPT1B gene", "Variant allele frequency"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspected CPT1B deficiency", "Family screening for CPT1B deficiency", "Recurrent muscle symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 81321-5 ICD-10: E71.314 Clinical summary This genetic test evaluates the CPT1B gene for pathogenic variants associated with Carnitine Palmitoyltransferase 1B deficiency.
TEST-3595 CRX Gene Cone-Rod Dystrophy Type 2 Genetic Test This test identifies pathogenic DNA variants in the entire CRX gene to confirm type 2 cone-rod dystrophy diagnosis.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic DNA variants in the CRX gene", "Copy Number Variants (CNVs) in the CRX gene"] Parameters [] Preparation ["No specific fasting required", "Disclose known bleeding disorders or anticoagulant therapy"] Indications ["Suspected cone-rod dystrophy type 2", "Family history of cone-rod dystrophy type 2"] Measurement technique Confirm with laboratory Codes LOINC: 85724-9 ICD-10: H35.52, H35.50 Clinical summary This test identifies pathogenic DNA variants in the entire CRX gene to confirm type 2 cone-rod dystrophy diagnosis.
TEST-3559 CRYAB Gene Posterior Polar Cataract Type 2 Genetic Test This test evaluates the CRYAB gene for pathogenic variants associated with posterior polar cataract type 2.	Peripheral blood (2-5 ml EDTA) or FTA card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CRYAB gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of blood transfusion within the last 14 days"] Indications ["Diagnosis of posterior polar cataract type 2", "Familial risk assessment", "Carrier detection"] Measurement technique Confirm with laboratory Codes LOINC: 101553-4 ICD-10: Q12.0, Z13.5, Z84.81 Clinical summary This test evaluates the CRYAB gene for pathogenic variants associated with posterior polar cataract type 2.
TEST-1679 CXCR4 Gene Mutation Analysis Test This test identifies pathogenic variants in the CXCR4 gene associated with WHIM syndrome, cancer predisposition, and hematopoietic stem cell homing defects.	Peripheral Whole Blood (3 mL EDTA)	7–8 Working Days	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CXCR4 gene"] Parameters [{"name": "CXCR4 Gene Mutation Status", "reference_range": "Negative (No pathogenic variant detected)"}] Preparation ["6-hour fasting period required", "Valid doctor’s prescription is mandatory (except for specific cases)"] Indications ["Suspected WHIM syndrome", "Metastatic cancer predisposition", "Hematopoietic stem cell homing defects", "Pre-surgical screening", "Antenatal genetic counseling", "Official travel-abroad screening"] Measurement technique Confirm with laboratory Codes LOINC: 81229-3 ICD-10: D81.0, Z15.89, Z13.79 Clinical summary This test identifies pathogenic variants in the CXCR4 gene associated with WHIM syndrome, cancer predisposition, and hematopoietic stem cell homing defects.
TEST-3274 CYBB Gene Genetic Test for X-Linked Chronic Granulomatous Disease This test identifies mutations in the CYBB gene associated with X-linked chronic granulomatous disease (CGD), a primary immunodeficiency.	Whole Blood (Peripheral Blood) or Extracted DNA; Dried Blood Spot (FTA Card) also accepted.	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYBB gene sequence", "Copy Number Variations (CNVs) in CYBB gene"] Parameters [] Preparation ["Prior genetic counselling session with pedigree charting is mandatory", "Disclose full medication history and current symptoms before sample collection"] Indications ["Clinical suspicion of X-linked CGD", "Documented family history of CGD", "Prior Genetic Counselling session"] Measurement technique Confirm with laboratory Codes LOINC: 101377-8 ICD-10: D82.0 Clinical summary This test identifies mutations in the CYBB gene associated with X-linked chronic granulomatous disease (CGD), a primary immunodeficiency.
TEST-6070 CYP11B1 Gene Adrenal Hyperplasia due to Steroid 11-Beta-Hydroxylase Deficiency Genetic Test This genetic test identifies mutations in the CYP11B1 gene associated with congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency.	Peripheral Whole Blood or FTA Card (Dried Blood Spot)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP11B1 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant family history"] Indications ["Suspected congenital adrenal hyperplasia", "Family history of CAH", "Need for precise CAH subtyping", "Carrier screening", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 90234-2 ICD-10: E25.0, E25.8, E25.9 Clinical summary This genetic test identifies mutations in the CYP11B1 gene associated with congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency.
TEST-6066 CYP21A2 Gene Genetic Test for Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency) This genetic test evaluates the CYP21A2 gene for mutations associated with 21-hydroxylase deficiency, the primary cause of Congenital Adrenal Hyperplasia (CAH).	Peripheral Whole Blood (or Extracted DNA, FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the CYP21A2 gene", "Point mutations", "Indels", "Copy number variations"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counselling is mandatory"] Indications ["Suspected CAH symptoms", "Family history of adrenal disorders", "Positive newborn screening", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 21532-9 ICD-10: E25.0, Z14.8 Clinical summary This genetic test evaluates the CYP21A2 gene for mutations associated with 21-hydroxylase deficiency, the primary cause of Congenital Adrenal Hyperplasia (CAH).
TEST-6196 CYP2C19 Genotyping (Drug Metabolism) Genetic Test This test evaluates genetic variants in the CYP2C19 gene to predict drug metabolism efficiency.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP2C19 gene variants (2, 3, *17, and others)", "Metabolizer phenotype (poor, intermediate, extensive, ultrarapid)"] Parameters [] Preparation ["Fasting is not required.", "Inform the phlebotomist of all current medications and supplements."] Indications ["Patients prescribed drugs metabolized by CYP2C19 (e.g., clopidogrel, PPIs, SSRIs)", "Patients experiencing adverse drug reactions or therapeutic failure with CYP2C19 substrates"] Measurement technique Confirm with laboratory Codes LOINC: 81803-3 ICD-10: Z13.81, Z84.8 Clinical summary This test evaluates genetic variants in the CYP2C19 gene to predict drug metabolism efficiency.
TEST-931 CYP2C19 Genotyping Test This test evaluates genetic variations in the CYP2C19 gene, which influence drug metabolism.	Peripheral Whole Blood	15 Working Days (from sample receipt)	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP2C19 gene variants (star alleles 2, 3, *17)", "Metaboliser status (Poor, Intermediate, Normal, Ultrarapid)"] Parameters [] Preparation ["No fasting required", "Avoid direct sunlight exposure on the blood sample after collection", "Ensure the sample is kept refrigerated"] Indications ["Before starting clopidogrel therapy", "To guide selection of antidepressants", "To guide selection of proton pump inhibitors"] Measurement technique Confirm with laboratory Codes LOINC: 21667-2 ICD-10: Z13.89 Clinical summary This test evaluates genetic variations in the CYP2C19 gene, which influence drug metabolism.
TEST-3992 CYP3A5 Gene Susceptibility to Salt‑Sensitive Essential Hypertension Genetic Test This test evaluates the CYP3A5 gene for variants associated with salt-sensitive essential hypertension and altered drug metabolism.	Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	10 to 14 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP3A5 gene variants (1, 3, 6, 7)", "Genetic predisposition to salt-sensitive hypertension"] Parameters [] Preparation ["No specific fasting required", "Inform genetic counsellor of all current medications"] Indications ["Assessment of genetic risk for salt-sensitive essential hypertension", "Guidance for personalized antihypertensive therapy selection", "Pharmacogenomic analysis for calcium channel blocker metabolism"] Measurement technique Confirm with laboratory Codes LOINC: 94483-8 ICD-10: I10, Z13.6 Clinical summary This test evaluates the CYP3A5 gene for variants associated with salt-sensitive essential hypertension and altered drug metabolism.
TEST-1677 Cystic Fibrosis (CFTR‑Del F508) Mutation Screening, Prenatal Test This test specifically screens for the presence of the CFTR‑Del F508 mutation in fetal DNA using targeted Sanger sequencing.	Amniotic fluid, chorionic villi, or umbilical cord blood	7–8 days	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence of CFTR‑Del F508 mutation"] Parameters [] Preparation [] Indications ["Prenatal screening for cystic fibrosis risk"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E84.9 Clinical summary This test specifically screens for the presence of the CFTR‑Del F508 mutation in fetal DNA using targeted Sanger sequencing.
TEST-930 Cystic Fibrosis Mutation Detection Test This diagnostic test evaluates the CFTR gene for pathogenic variants associated with cystic fibrosis.	Peripheral Whole Blood or Amniotic Fluid	6 weeks	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CFTR gene", "Presence of mutations causing cystic fibrosis"] Parameters [] Preparation ["Inform physician if on anticoagulants", "Amniotic fluid collection requires obstetric guidance"] Indications ["Newborns with positive CF newborn screening", "Children with recurrent respiratory infections", "Individuals with a family history of cystic fibrosis", "Preconception carrier screening for high-risk populations"] Measurement technique Confirm with laboratory Codes LOINC: 47647-9 ICD-10: E84.9 Clinical summary This diagnostic test evaluates the CFTR gene for pathogenic variants associated with cystic fibrosis.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories